ABSTRACT The accuracy of a prediction equation for assessing the lowest arterial oxygen saturation (Sao2) during sleep was determined in 24 consecutive patients with chronic obstructive lung disease referred for assessment for home oxygen therapy. Subjects had a mean (SD) FEV, of 0 81 (0 31) litre and an FEV,/FVC of 37% (12%). There was reasonable agreement between predicted and measured values (mean difference [predicted-measured] = -2-5%) but the prediction was not precise as the 95°% confidence interval for the difference was +8% to -13%.
Hypoxaemic patients with chronic obstructive lung disease are often prescribed continuous home oxygen on the basis of daytime measurements made with the subject awake. Indications include significant, persistent hypoxaemia (arterial oxygen tension (Pao2) < 56 mm Hg (7 5 kPa) on two occasions at least three weeks apart), or hypoxaemia (Pao2 56-59 mm Hg (7 5-7 9 kPa) accompanied by polycythaemia or right heart failure.`3 It has been postulated that patients without appreciable daytime hypoxaemia may have nocturnal desaturation severe enough to lead eventually to polycythaemia and cor pulmonale.' If such patients are to be prescribed oxygen, sleep studies would be required unless oxygenation during sleep could be predicted accurately.7 "Awake" oxygen saturation (Sao2) and lowest Sao2 recorded during sleep are correlated in patients with chronic obstructive lung disease,>" and Connaughton and associates'2 recently described an equation that predicted the lowest oxygen saturation during sleep (lowest Sao2 asleep (%) = 1 -98 Sao2 awake -103, r = 0 82). The present study was designed to examine whether by using this equation arterial desaturation during sleep could be accurately predicted from measurements made when the subject was awake.
Methods
Twenty four consecutive patients with chronic obstructive lung disease who were referred for assessment of their suitability for home oxygen therapy were studied during sleep . The mean (SEM) % TST spent below 85% Sao2 (TST < 85%) and 75% Sao2 was 38(9)% and 6% (3)% respectively. The duration of desaturation (TST<85) was related to awake Sao2 (Spearman rank correlation (rs) = -0-82), but the prediction equation obtained Multiple stepwise regression analysis using awake Sao2, Pao2, Paco2, packed cell volume and lowest Sao2 during sleep showed that only awake Sao2 and packed cell volume were independent predictors of lowest Sao2 during sleep (multiple R = 0 90). Figure 3 shows the relation between the lowest Sao2 during sleep and Sao2 measured by ear oximetry with the subject sitting, awake, on the night of the study. The regression equation and 95% confidence limits for the predicted lowest Sao2 asleep are shown in the figure. A similar relation was found between awake Sao2 measured in the clinic three weeks before the study and the lowest Sao2 during sleep (lowest Sao2 during sleep = 2-4 x awake Sao2 -137; r2 = 0 76).
--------------------------.Mean
In five patients the oxygen flow rate required to maintain Sao2 above 90% during sleep was at least 1 0 I/min more than that required to maintain Sao2 above 90% while subjects were awake. Only one patient, however, required an addition of more than 1[5 1/min. Thus an empirically determined addition of 1-5 I/min to the "awake" oxygen flow rate would have maintained Sao2 above 90% during sleep in 23 out of 24 patients.
Discussion
In 24 consecutive patients with chronic obstructive lung disease referred for home oxygen therapy we found wide confidence limits for the difference between Sao2 measured during sleep and values obtained from a prediction equation based on Sao2 measured with the subject awake. When applied to large numbers of patients with chronic obstructive lung disease therefore the equation is not likely to identify those who have arterial oxygen desaturation during sleep with sufficient accuracy to be clinically useful.
The patients in the present study did not sleep as well as patients.with chronic obstructive lung disease studied by others." '8'9 All but one patient in the present study, however, had REM sleep and the depth and duration of nocturnal arterial oxygen desaturation were similar to those reported previously. We are unlikely to have underestimated the severity of nocturnal oxygen desaturation in our patients.
In the study of Connaughton and associates'2 Sao2
was measured with a Hewlett Packard 47201A ear oximeter, whereas we used a Biox IIA oximeter. Recently, West and associates20 compared the Hewlett Packard 47201A ear oximeter with the Biox III ear oximeter during rapid oscillations in Sao2 in patients with obstructive sleep apnoea. They found that the Biox pulse oximeter measurements were generally higher than those simultaneously recorded by the Hewlett Packard transmittance oximeter. The difference between the mean lowest Sao2 values recorded by the two oximeters was 3%. Although rapid changes in Sao2 during sleep did not occur frequently in the patients we studied, the use of a Biox IIA rather than a Hewlett Packard 47201A oximeter may explain part of the bias between measured and predicted values in our study. It is, however, unlikely to explain the lack of precision that we observed. We confirmed the close relationship between lowest Sao2 during sleep and "awake" Sao2 '4 and found prediction equations similar to that of Connaughton and associates.'2 The oximeter Sao2 measured in the clinic one to three weeks before the sleep study was similar in predictive accuracy to the Sao2 measured by the oximeter with subjects sitting and awake on the night ofthe study (r2 = 0-76 and 0-64 respectively). We also confirmed the relation between duration of desaturation during sleep (TST<85) and awake Sao2, . 316 but we found that the awake Sao2 was a poor predictor ofTST<85 (r2 = 0 53). The oxygen flow rate required to maintain Sao2 at over 90% during sleep could not be predicted accurately; but the addition of 1[5 1/min (an amount decided empirically) to the oxygen flow rate required to achieve an arterial oxygen Sao2 of 90% while the patient was awake would have been adequate during sleep in most cases.
Several issues relating to the clinical utility of a prediction equation for prescribing home oxygen have to be considered. Firstly, in the absence of daytime hypoxaemia, are episodes of nocturnal hypoxaemia harmful? The opinion of the American Thoracic Society is as follows: "Though it is not established that such episodes are harmful, it is probably unwise to assume that they are harmless, and we believe nocturnal oxygen therapy can be justified in such episodes."2'
On the other hand, there is evidence that the extent of nocturnal hypoxaemia is not clinically important.2223 At the present, therefore, the clinical importance of "isolated" nocturnal hypoxaemia is controversial and largely unknown.
The second issue is the precision of the prediction McKeon, Murree-Allen, Saunders therapy on the basis of measurements made while they are awake do not require a sleep study since nocturnal oxygen flow rates can be effectively prescribed in an empirical fashion in most cases. If home oxygen therapy is to be prescribed to patients who do not qualify for oxygen therapy on the basis of awake measurements, but who are suspected of having nocturnal hypoxaemia because of polycythaemia, right heart failure, or hypercapnia, a formal sleep study to document the extent of arterial oxygen desaturation during sleep may be required. The efficacy of home oxygen therapy in this group of patients has not, however, been established in a long term, randomised clinical trial.
